Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 5.47 | 12.72 |
| PEG Ratio (TTM) | -0.73 | 1.73 |
| P/S Ratio (TTM) | 1.38 | 2.67 |
| P/B Ratio (TTM) | 0.85 | 1.74 |
| P/FCF Ratio (TTM) | -2.30 | -12.68 |
| Price to 5YR AVG Earnings Ratio | 5.69 | 9.11 |
| Price to 5YR AVG FCF Ratio | -3.71 | 5.98 |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.62% | 1.68% |
| ROE (TTM) | 16.55% | 16.43% |
| Net Profit Margin (TTM) | 25.20% | 23.28% |
| ROIC 5YR AVG | 16.85% | 15.11% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -6.58% | 58.68% | 39.21% |
| Revenue | 19.01% | 51.55% | 35.24% |
| Net Income | -6.15% | 60.75% | 41.22% |
| Cash Flow | -216.80% | -197.55% | 270.69% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 34.19 | 6.22 |
| Quick Ratio (TTM) | 34.19 | 6.32 |
| D/E Ratio (TTM) | 1.84 | 1.58 |
| Interest Coverage (TTM) | 1.45 | 0.81 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 1.05 | 0.45 |
| LTL to 5YR AVG FCF | -0.48 | 7.83 |
| Shares Outstanding Growth 5YR AVG | 0.09% | 1,894.83% |